Publications by authors named "Juliana Isa Beraldo"
Article Synopsis
- Dipeptidyl peptidase IV (DPPIV) inhibitors, like sitagliptin, not only help lower blood sugar but also provide kidney protection and may reduce cardiac dysfunction in chronic kidney disease (CKD).
- In a rat study, DPPIV inhibition improved heart health by decreasing issues like cardiac hypertrophy and fibrosis, as well as mitigating diastolic dysfunction associated with kidney failure.
- The research suggests that the positive effects of DPPIV inhibitors are linked to restoring balance in the heart's renin-angiotensin system, indicating a potential connection between DPPIV and heart-kidney health issues.
